Multi-Product Series
Precision-extracted botanical powders and essential oils, standardized against distinct active markers with comprehensive USP/EP contaminant validation.
Multi-Product Series
10:1 Concentrated
Nootropic Grade
Nutricosmetic
High Polyphenol
Steam Distilled / Pressed
Finished OEM/ODM
Advanced Bioavailability
Mitigating cross-border botanical supply chain failure through verified scientific assays, complete audit trails, and strict adherence to Western pharmacopeial monographs.
Every industrial delivery is accompanied by full technical documentation including lot-specific COA, FTIR identity spectrums, residual solvent declarations (USP <467>), pesticide screens (EP 2.8.13), and validated elemental impurity reports (USP <232>/<233>).
Utilizing clean ethanol counter-current extraction, supercritical CO2 fluid fractionation, and low-temperature membrane concentration technologies, we preserve thermolabile botanical constituents while completely eliminating hazardous aromatic hydrocarbons.
With operational headquarters in the United Kingdom and audited manufacturing bases in China, Nutraspect integrates local European customer support with direct-from-source price competitiveness, verified Incoterms (DDP/CIF), and dedicated buffer stock arrangements.
The global pharmaceutical and clinical nutraceutical sector is moving decisively away from generic extraction ratios (e.g., crude 10:1 or 20:1) toward quantified, HPLC-fingerprinted active marker assays. Procurement directors now mandate chromatographic profiling to mitigate intentional adulteration and ensure consistent pharmacokinetics across production runs.
Poor aqueous solubility has traditionally limited the therapeutic application of hydrophobic phytochemicals such as Curcumin, Berberine, and Boswellic Acids. The market is shifting rapidly toward liposomal encapsulation, phospholipid complexes, and self-microemulsifying drug delivery systems (SMEDDS) that amplify human in-vivo absorption by up to 20 to 40 times.
Adoption of green extraction principles to comply with FDA and EMA Class 1 & Class 2 solvent prohibitions, prioritizing supercritical fluid carbon dioxide and food-grade bio-ethanol.
Routine implementation of genomic sequencing alongside morphological and HPTLC testing to guarantee botanical genus and species integrity without adulteration.
Non-thermal sterilization and validated low-heat steam treatments designed to achieve total aerobic microbial counts <1000 CFU/g without radiation degradation of active phyto-compounds.
Nutraspect standard operating procedures benchmark each active batch against rigorous international monograph criteria.
| Botanical Product | Target Active Marker | Assay Standard | Primary Analytical Method | Impurity Limits (Pb/As/Cd/Hg) |
|---|---|---|---|---|
| Curcuma longa (Liposome Curcumin) | Total Curcuminoids (Curcumin, Demethoxy, Bisdemethoxy) | ≥ 95.0% on Dried Basis | Reversed-Phase HPLC-DAD | ≤ 0.5 / ≤ 0.5 / ≤ 0.2 / ≤ 0.1 ppm |
| Radix Astragali Extract | Astragaloside IV & Bioactive Polysaccharides | 0.3% - 10.0% / ≥ 50% | HPLC-ELSD / UV-Vis Spectrometry | ≤ 1.0 / ≤ 0.5 / ≤ 0.3 / ≤ 0.1 ppm |
| Camellia sinensis (Green Tea) | Total Polyphenols / (-)-EGCG | ≥ 98.0% / ≥ 50.0% | USP <621> Chromatography | ≤ 0.5 / ≤ 0.5 / ≤ 0.2 / ≤ 0.1 ppm |
| Hericium erinaceus (Lion's Mane) | Soluble β-1,3-1,6-D-Glucans | ≥ 30.0% Bioactive Glucans | Megazyme Enzymatic Assay | ≤ 1.0 / ≤ 1.0 / ≤ 0.5 / ≤ 0.1 ppm |
| Clove Leaf Essential Oil | Eugenol & β-Caryophyllene | ≥ 85.0% Eugenol Fraction | Capillary GC-MS / GC-FID | USP Compliant Essential Oil Screen |
Addressing the technical, regulatory, and supply chain questions encountered during supplier qualification.
We source raw medicinal materials from dedicated, Good Agricultural and Collection Practices (GACP) compliant cultivation bases. During extraction, incoming raw biomass is classified according to active marker concentration. Our automated continuous extraction platforms blend and calibrate extraction variables under tight feedback loops to yield finished extract powders within ±1.5% of target standardisation.
In addition to our internal cGMP laboratory equipped with Agilent HPLC-DAD, Shimadzu GC-MS, and PerkinElmer ICP-MS instruments, representative samples from every commercial production lot are counter-tested by ISO/IEC 17025 accredited independent third-party laboratories (such as Eurofins and SGS) to verify pesticide multiresidues, polycyclic aromatic hydrocarbons (PAH4), and heavy metals.
Yes. We offer custom air-classifier milling to achieve micronization from 80 mesh up to 300 mesh for precise capsule filling, tablet direct compression, or suspension stability. Furthermore, we develop clean-label carrier systems, substituting synthetic maltodextrin or silica with organic acacia fiber, rice flour, or non-GMO sunflower lecithin upon contractual agreement.
Our regulatory desk issues full Quality Dossiers containing: Manufacturing Process Flowcharts with critical control points (HACCP), Allergen & GMO Free Statements, TSE/BSE Compliance, Residual Solvent Profiles, Continuous Temperature Data Logs during shipment, and valid cGMP, ISO9001, ISO22000, Kosher, and Halal facility accreditation certificates.
Request comprehensive pilot samples, technical specifications, and manufacturer-direct pricing for your next production campaign. Our technical sales team provides responsive, bilingual support.